Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab
Clinical trial NCT03212651 · COMPLETED
Trial details
- NCT number
- NCT03212651
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2019-07-18
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.